WOW, Check out Howard Colman, MD, PhD, above tweet, describing key innovations for GBM AGILE.
He states the study framework could potentially speed up the FDA approval process by allowing confirmatory data accrued during the ongoing study arm for the drug to be used and submitted to the FDA to consider an approval. This allows the drug to reach patients quicker than the time it takes for FDA approval from traditional trials.
Regards.
- Forums
- ASX - By Stock
- KZA
- Ann: Kazia commences recruitment to GBM AGILE
Ann: Kazia commences recruitment to GBM AGILE, page-9
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online